AONC

American Oncology Network, Inc.
—

Company Information

Company Name
American Oncology Network, Inc.
CIK
CIK0001839998
Category
Non-accelerated filer<br>Smaller reporting company
Ticker: Exchange
AONC: OTC, AONCW: OTC
Fiscal Year End
December 31
Owner Organization
08 Industrial Applications and Services
SIC
8000
SIC Description
Services-Health Services
Ticker
AONC

SEC filing data through

Insider Sentiment

Last purchase
2024-05-24
Last sale
2023-09-25
Shares purchased (TTM)
10,340
Shares sold (TTM)
205,512
Buy ratio (TTM)4.8%

Institutional Sentiment

As of
2025-03-31
Institutional shares owned
27,101
Shares outstanding
13,717,309
Ownership
0.20%
-1.13% Y/Y

Earnings Market Reaction

Filing date
2025-03-27
Price on filing date
—
1-month reaction
20.00%
3-month reaction
120.00%
Drift continued2/3 (67%)
Faded / reversed1/3 (33%)

Balance Sheet

Values in millions ($)
Line item2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Capital Unit Class A----0-19,495--1919--
Common Class B0-6-324025006-808
Assets
Capital Unit Class A1----0-2,282--22--
Assets Current
Cash And Cash Equivalents At Carrying Value6319347529520027001
Prepaid Expense Current------000000
Available For Sale Securities Debt Securities10021303526--10---
Accounts Receivable Net Current129128125132129141--136---
Inventory Net614954444538--36---
Other Receivables Net Current586361353437--28---
Prepaid Expense And Other Assets Current898543--3---
Notes And Loans Receivable Net Current222222--2---
Assets Current33127130632427829800242011
Deferred Income Tax Liabilities Net--------1---
Assets Held In Trust Noncurrent------1919338336334334
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization484543414036--32---
Operating Lease Right Of Use Asset504651434346--44---
Notes And Loans Receivable Net Noncurrent100012--2---
Other Assets Noncurrent26--1287--5---
Intangible Assets Net Including Goodwill---111--1---
Goodwill111111-1-------
Intangible Assets Net Excluding Goodwill222-0-------
Deferred Income Tax Assets Net000033--0---
Other Assets-1918---------
Assets4703954314223743941919326336335335
Accounts Payable And Accrued Liabilities Current And Noncurrent------443211
Notes Payable Related Parties Classified Current-------0----
Notes Payable Current------0-----
Other Liabilities Current------0-----
Accrued Income Taxes Current------1-----
Sales And Excise Tax Payable Current------33----
Liabilities And Stockholders Equity
Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares------211146
Liabilities Current
Accounts Payable Current171155189188128120--106---
Employee Related Liabilities Current171512131116--7---
Other Accrued Liabilities Current181718252223--18---
Taxes Payable Current111111--0---
Operating Lease Liability Current777777--9---
Long Term Debt Current444-0-------
Liabilities Current21720023223416916897141211
Long Term Debt Noncurrent878888818180--80---
Operating Lease Liability Noncurrent484446404042--37---
Other Liabilities Noncurrent101011111410--6---
Liabilities3623413773663043011120264151718
Preferred Stock Number Of Shares Par Value And Other Disclosures
Common Classa Not Subject To Redemption------0800--
Temporary Equity Carrying Amount Attributable To Parent65656565656563-----
Redeemable Noncontrolling Interest Equity Carrying Amount889228158167369------
Stockholders Equity
Preferred Stock Par Or Stated Value Per Share------0.000.000.000.000.000.00
Preferred Stock Shares Authorized------111111
Preferred Stock Shares Issued------000000
Preferred Stock Shares Outstanding------000000
Additional Paid In Capital5602780011-----
Treasury Stock Common Value-0-0-0-00-------
Accumulated Other Comprehensive Income Loss Net Of Tax000000---0---
Retained Earnings Accumulated Deficit-102-103-67-176-162-341-21-2026-14-16-17
Members Equity--------6261--
Stockholders Equity-45-104-40-167-162-341-10-20-14-14-16-17
Minority Interest211100------
Liabilities And Stockholders Equity4703954314223743941919326336335335
Common Classa Subject To Redemption------02330033
Series A Preferred Stock000007------
Common Class A-143130-10819800
Related Party9-14111111--13---
Temporary Equity Shares Outstanding7777772-----
Capital Unit Class B----0-0--50--
Treasury Stock Common Shares-0000-0-------

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

American Oncology Network, Inc. (AONC) — SEC Financial Statements & Analysis

American Oncology Network, Inc. (AONC) is a services-health services company, incorporated in DE. American Oncology Network, Inc. trades on OTC as: AONC, AONCW. American Oncology Network, Inc. (AONC)'s most recent SEC filing is a Form 10-K for the period ended 2024-12-31, filed with the SEC on 2025-03-27. Based on its latest SEC filing (Form 10-Q, period ending 2024-12-31), American Oncology Network, Inc. carries a market cap of $69.41M, a P/E ratio of -2.57x, a P/B ratio of -1.56x, a P/S ratio of 0.04x, an enterprise value of $97.43M, and an EV/EBITDA multiple of -14.09x. On profitability, it posts a gross margin of 6.70%, an operating margin of -0.99%, a net margin of -1.53%, a Return on Equity (ROE) of 26.18%, a Return on Assets (ROA) of -6.38%, and a Return on Invested Capital (ROIC) of -124898.01%. Per share, it reports EPS of $-1.97, diluted EPS of $-0.72, free cash flow per share of $-1.89, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 37.55% year-over-year, net income growth of 386.43% year-over-year, and EPS growth of 137.08% year-over-year. On the balance sheet, it maintains a current ratio of 1.53x, a quick ratio of 1.21x, working capital of $114.63M, a debt-to-equity ratio of -8.12x, a debt ratio of 0.77, an interest coverage ratio of -1.98x, free cash flow of $-25.90M (TTM), and net debt of $28.02M. Figures sourced from SEC EDGAR.

Market Cap
$69.41M
P/E TTM
-2.57x
EPS TTM
$-1.97
P/B TTM
-1.56x
ROE TTM
26.18%
ROA TTM
-6.38%
Debt To Equity
-8.12x
Free Cash Flow TTM
$-25.90M
Net Revenue TTM Growth 1Y
37.55%

Data as of 2024-12-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is American Oncology Network, Inc. in?

American Oncology Network, Inc. (AONC) operates in the Services-Health Services industry.

What exchange does AONC trade on?

American Oncology Network, Inc. (AONC) trades on the OTC.

Where is American Oncology Network, Inc. incorporated?

American Oncology Network, Inc. is incorporated in DE.

When was American Oncology Network, Inc. (AONC)'s most recent SEC filing?

American Oncology Network, Inc. (AONC)'s most recent SEC filing is a Form 10-K for the period ended 2024-12-31, filed with the SEC on 2025-03-27.

What is AONC's market cap?

American Oncology Network, Inc. (AONC) has a market capitalization of $69.41M as of 2024-12-31.

What is AONC's EPS (earnings per share)?

American Oncology Network, Inc. (AONC)'s trailing twelve month EPS is $-1.97 as of 2024-12-31.

What is AONC's ROE (return on equity)?

American Oncology Network, Inc. (AONC)'s trailing twelve month Return on Equity (ROE) is 26.18% as of 2024-12-31.

What is AONC's ROA (return on assets)?

American Oncology Network, Inc. (AONC)'s trailing twelve month Return on Assets (ROA) is -6.38% as of 2024-12-31.

What is AONC's ROIC (return on invested capital)?

American Oncology Network, Inc. (AONC)'s trailing twelve month Return on Invested Capital (ROIC) is -124898.01% as of 2024-06-30.

What is AONC's EV/EBITDA?

American Oncology Network, Inc. (AONC)'s trailing twelve month EV/EBITDA is -14.09x as of 2024-12-31.

Wall Street's data.
Main Street's price.